Based on previous studies and publication research, we hypothesized that ATM (ataxia telangiectasia mutant gene), ATR (ataxia telangiectasia and Rad3 related) and CAT (catalase) polymorphisms may be related to the prognosis of lung cancer patients receiving platinum-chemotherapy[8–10]. The gene discussed is ATR; the disease is lung cancer.